CBC Group announced its CBC China Life Science Infrastructure Venture (CLSIV) fund held a first close of $500 million with a hard cap of $1.5 billion in total equity. The fund was formed to provide best-in-class facilities for life science research, manufacturing and support services in China . CBC Group, which claims to be Asia's largest healthcare-dedicated investment firm, formed a partnership with the Netherlands ' APG Asset Management to sponsor the CBC Healthcare Infrastructure Platform (CBC HIP), which includes the China-focused life science infrastructure fund as one of its offerings. More details.... Share this with colleagues: // //